Citation Impact
Citing Papers
Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy
2014 Standout
B7-H4 Expression in Human Melanoma: Its Association with Patients' Survival and Antitumor Immune Response
2011
Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma
2012
Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA‐induced silencing complex (RISC) components argonaute‐1, argonaute‐2, PACT, TARBP1, and TARBP2 in epithelial skin cancer
2011
Microbial Signatures Associated with Oropharyngeal and Oral Squamous Cell Carcinomas
2017
Head and neck squamous cell carcinoma
2020 Standout
A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma
2015
Heparin-Protein Interactions
2002 Standout
Structure and Biological Activity of Heparin
1985
Cancer immunoediting: from immunosurveillance to tumor escape
2002 Standout
Malignant melanoma in a man seropositive for the human immunodeficiency virus
1989
The Effectiveness of Mobile-Health Technologies to Improve Health Care Service Delivery Processes: A Systematic Review and Meta-Analysis
2013 Standout
The prognosis of primary and metastasising melanoma. An evaluation of the TNM classification in 2,495 patients
1992
Up-regulation of Ago2 expression in gastric carcinoma
2013
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
Wnt signaling in cancer
2016 Standout
Technical Details of Intraoperative Lymphatic Mapping for Early Stage Melanoma
1992 Standout
The Prognostic Implications of Microscopic Satellites in Patients With Clinical Stage I Melanoma
1991
Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment
2016 Standout
Dermatologist-level classification of skin cancer with deep neural networks
2017 StandoutNature
Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer
1999
Therapy for cutaneous melanoma: An update
1990
The Protective Role of Melanin Against UV Damage in Human Skin†
2007 Standout
Cutaneous melanoma: Prognosis and treatment results worldwide
1992
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
1997 Standout
The Epidemiology of Skin Cancer
1996 Standout
The National Cancer Data Base report on cutaneous and noncutaneous melanoma
1998 Standout
Model Predicting Survival in Stage I Melanoma Based on Tumor Progression
1989 Standout
Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
2018 Standout
Early Diagnosis of Cutaneous Melanoma
2004
Distinct Sets of Genetic Alterations in Melanoma
2005 Standout
MicroRNA biogenesis pathways in cancer
2015 Standout
Cutaneous Melanoma
1991
A Comprehensive Guide to the MAGE Family of Ubiquitin Ligases
2017
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
2017 Standout
Objective histopathologic grading of cutaneous malignant melanomas by stereologic estimation of nuclear volume. Prediction of survival and disease-free period
1990
Tumour-infiltrating lymphocytes in melanoma prognosis and cancer immunotherapy
2016
Age as a prognostic factor in the malignant melanoma population
1994
Control of the localization and function of a miRNA silencing component TNRC6A by Argonaute protein
2015
Prognostic Factors in Thin Cutaneous Malignant Melanoma
1990
PROTAC targeted protein degraders: the past is prologue
2022 Standout
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma
1994 Standout
Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.
1996 Standout
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
Association of early malignant melanoma with nevocytic nevi
1989
Malignant melanoma in the 1990s: the continued importance of early detection and the role of physician examination and self-examination of the skin
1991
Cutaneous malignant melanoma (arizona cancer center experience). I. Natural history and prognostic factors influencing survival in patients with stage i disease
1988
Bladder cancer: Epidemiology, staging and grading, and diagnosis
2005 Standout
The new stereological tools: Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis
1988 Standout
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
2011 StandoutNobel
Effect of BANS location on the prognosis of clinical stage I melanoma: new data and meta-analysis
1988
Predicting extravesical extension of bladder carcinoma: a novel method based on micrometer measurement of the depth of invasion in transurethral resection specimens
2000
The role of MicroRNAs in human cancer
2016 Standout
Modeling neurodevelopmental disorder-associated humanAGO1mutations inCaenorhabditis elegansArgonautealg-1
2024 StandoutNobel
Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma
2012
Invasive Cutaneous Melanoma in Elderly Patients
1991
The Three Es of Cancer Immunoediting
2004 Standout
Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System
2001 Standout
TIMER2.0 for analysis of tumor-infiltrating immune cells
2020 Standout
Predicting ten-year survival of patients with primary cutaneous melanoma: corroboration of a prognostic model.
1997
Predicting ten-year survival of patients with primary cutaneous melanoma
1997
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma.
2009
A Comparison of Prognostic Factors and Surgical Results in 1,786 Patients with Localized (Stage I) Melanoma Treated in Alabama, USA, and New South Wales, Australia
1982
Breslow thickness and Clark level in melanoma
2000
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Multivariate analysis. Some guidelines for physicians
1983
Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
2000
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 StandoutNobel
Prognostic factors for stagei melanoma of the skin: A review
1985
CD8+tumor-infiltrating lymphocytes at primary sites as a possible prognostic factor of cutaneous angiosarcoma
2013 StandoutNobel
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
2001 Standout
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
Malignant Melanoma Prognostic Factors 7: Elective Lymph Node Dissection
1985
Prognostic histopathological factors in malignant melanoma
1985
Up-Regulation of PD-L1, IDO, and T regs in the Melanoma Tumor Microenvironment Is Driven by CD8 + T Cells
2013 Standout
Malignant Melanoma
1981
Tissue-specific expression of B7x protects from CD4 T cell–mediated autoimmunity
2011 StandoutNobel
Incontinence and Troublesome Behaviors Predict Institutionalization in Dementia
1992 Standout
UV Radiation and the Skin
2013 Standout
Cutaneous Malignant Melanoma: Prognostic Guidelines for Physicians and Patients
1982
Works of Patrick Hennessey being referenced
Expression Microarray Analysis Reveals Alternative Splicing of LAMA3 and DST Genes in Head and Neck Squamous Cell Carcinoma
2014
MAGEB2 is Activated by Promoter Demethylation in Head and Neck Squamous Cell Carcinoma
2012
EIF2C Is Overexpressed and Amplified in Head and Neck Squamous Cell Carcinoma
2010
Novel Insight into Mutational Landscape of Head and Neck Squamous Cell Carcinoma
2014
A Prognostic Model for Clinical Stage I Melanoma of the Upper Extremity. The Importance of Anatomic Subsites in Predicting Recurrent Disease
1981
A prognostic model for clinical stage I melanoma of the trunk
1981
Factors Related to Thickness of Melanoma
1981
Influence of anatomic location on prognosis of malignant melanoma: Attempt to verify the BANS model
1986
Congenital nevocytic nevi and malignant melanomas
1979
Correlation of Thicknesses of Superficial Spreading Malignant Melanomas and Ages of Patients
1981
Thickness of Malignant Melanoma: Global Analysis of Related Factors
1987
A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease.
1981
Preparative Countercurrent Chromatography for Isolation of Charge Density-Fractionated Heparin
1982